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Abstract
Objective: Understanding factors that affect postoperative length of stay (LOS) may
improve patient recovery, hasten postoperative discharge, and minimize institutional
costs. This study sought to (a) describe LOS among head and neck patients undergo-
ing free flap reconstruction and (b) identify factors that predict increased LOS.
Methods: A retrospective cohort was performed of 282 head and neck patients with
free flap reconstruction for oncologic resection between 2011 and 2013 at a tertiary
academic medical center. Patient demographics, tumor characteristics, and surgical
and infectious complications were characterized. Multivariable regression identified
predictors of increased LOS.
Results: A total of 282 patients were included. Mean age was 64.7 years (SD = 12.2)
and 40% were female. Most tumors were located in the oral cavity (53.9% of
patients), and most patients underwent radial forearm free flap (RFFF) reconstruction
(RFFF—73.8%, anterolateral thigh flap—11.3%, and fibula free flap—14.9%).
Intraoperative complications were rare. The most common postoperative complica-
tions included nonwound infection (pneumonia [PNA] or urinary tract infection [UTI])
(15.6%) and wound breakdown/fistula (15.2%). Mean and median LOS were 13 days
(SD = 7.7) and 10 days (interquartile range = 7), respectively. Statistically significant
predictors of increased LOS included flap take back (Beta coefficient [C] = +4.26,
P < .0001), in-hospital PNA or UTI (C = +2.52, P = .037), wound breakdown or fistula
(C = +5.0, P < .0001), surgical site infection (C = +3.54, P = .017), and prior radiation
therapy (C = +2.59, P = .004).
Conclusion: Several perioperative factors are associated with increased LOS. These
findings may help with perioperative planning, including the need for vigilant wound
care, optimization of antibiotics prophylaxis, and institution-level protocols for post-
operative care and disposition of free flap patients.
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Level of Evidence: 2b; retrospective cohort.
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1 | INTRODUCTION
Head and neck cancer patients undergoing free flap reconstruction
have variable inpatient length of stay (LOS), ranging from days to weeks
to months.1-3 Variation in LOS has important clinical implications for
patient recovery, placement in rehabilitation and acute care facilities, and
the initiation of adjuvant multimodality therapy.4,5 Additionally, LOS is
associated with significant hospital costs.6,7 Prior studies across various
surgical specialties have identified several risk factors associated with
increased LOS, including American Society of Anesthesiology (ASA)
score, pre- and postoperative hemoglobin levels, age, comorbidities, and
need for blood transfusion, and have successfully targeted these to
decrease LOS, reduce cost, and improve quality of care.8-11
Several factors have been associated with variability in LOS spe-
cifically among head and neck cancer patients. These include age,
recent weight loss, excess alcohol use, malnutrition, history of diabe-
tes, ASA score, Kaplan Feinstein comorbidity index (KFI) score, low
preoperative hemoglobin, mucosal surgery, crystalloid replacement
volume, and anesthesia or procedure duration.1,2,12-15 While past
head and neck studies have explored clinical risk factors associated
with increased LOS, there is a lack of studies that stratify by flap type
and include a wider range of risk factors.
Overall, LOS is an important outcome metric monitored by
insurers and quality organizations, and a marker of hospital quality
associated with cost of care and patient outcomes. Therefore, this
study aims to (a) describe LOS among head and neck patients under-
going free flap reconstruction and (b) identify factors that may predict
increased LOS.
2 | MATERIALS AND METHODS
A retrospective review of all patients (N = 282) who underwent free
flap reconstruction, including anterolateral thigh flap (ALT), fibula free
flap (FFF), or radial forearm free flap (RFFF) reconstruction after onco-
logic resection at a major tertiary care center between 2011 and 2013
was performed. Data for this study were derived, in part, from a previ-
ous retrospective cohort study investigating risk factors associated
with increased operative time.16 Institutional Review Board approval
was obtained.
LOS data were collected for each patient, and was defined as
the time between the day of surgery and the day of hospital dis-
charge. Patient demographics, cancer staging, and clinical data
such as previous cancer treatment, tumor site, and comorbidities
were collected. Inpatient events were characterized including flap
take back (defined as flap failure or compromise requiring surgical
intervention), postoperative transfusion, wound breakdown or fistula not
related to infection, surgical site infection (SSI; both recipient and donor
sites), and postoperative cardiac (myocardial infarction, arrhythmia,
congestive heart failure), pulmonary (pulmonary embolism, respira-
tory distress or failure) and infectious complications (urinary tract
infection [UTI], pneumonia [PNA]). Antibiotic prophylaxis protocol at
TABLE 1 Patient demographics
Variable Number (%)
Age, mean (SD) 64.7 (12.2)
Female gender 112 (39.7)
ASA 3 or 4 169 (59.9)
Stage I-III 137 (54.8)









Oral cavity 152 (53.9)
Oropharynx 24 (8.5)
Sinus/maxilla 25 (8.9)
ORN (yes) 20 (7.1)
Preoperative XRT 126 (44.7)
Packed Red Blood Cell transfusion 138 (48.9)
Flap take back (yes) 37 (13.1)
In-hospital cardiac issue 21 (7.5)
In-hospital pulmonary issue 22 (7.8)
In-hospital nonwound infection (PNA or UTI) 44 (15.6)
In-hospital wound breakdown or fistula 43 (15.2)
In-hospital surgical site infection 25 (8.9)
LOS (d), mean (SD) 13.0 (7.7)
LOS (d), median (IQR) 10.0 (7.0)
Note: Surgical site infection includes both donor and recipient sites. Table
adapted from Lindeborg et al.16
Abbreviations: ALT, anterolateral thigh; ASA, American Society of Anes-
thesiology Physical Classification; FFF, fibular free flap; IQR, interquartile
range; LOS, length of stay; ORN, osteoradionecrosis; PNA, pneumonia;
RFFF, Radial forearm free flap; UTI, urinary tract infection; XRT, radiation.
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study site was to stop antibiotic prophylaxis 24 hours after first
perioperative prophylactic dose.
Patient characteristics and inpatient events were characterized
descriptively and stratified by flap type. Univariable comparisons were
performed using Student's t test, chi-square test, and the Kruskal-
Wallis test where appropriate. A linear multivariable regression analy-
sis was performed to identify predictors of increased LOS. All data
manipulation and statistical analysis were performed using STATA
v13 (STATA Corp, North Carolina).
3 | RESULTS
3.1 | Patient characteristics
A total of 282 patients underwent RFFF (N = 208, 73.8%), FFF
(N = 42, 14.9%), or ALT (N = 32, 11.3%) reconstruction after oncologic
resection and were included in the study (Table 1).
Mean patient age was 64.7 years (SD = 12.2 years), 40% of
patients were female, and 59.9% of patients had an American Society
of Anesthesiologists (ASA) Physical Status Classification System status
of 3 or 4. A high proportion of patients had advanced stage cancer,
with 45.2% stage IV and 54.8% stage I to III. The most common tumor
site was the oral cavity (53.9%). Forty-four percent of patients had
received prior radiation therapy. Postoperatively, 48.9% of patients
received packed red blood cell transfusion. The most common postop-
erative complications were nonwound infection (PNA or UTI) (15.6%)
and wound breakdown or fistula (15.2%).
3.2 | Pre- and perioperative factors by flap type
Patient demographics, tumor characteristics, and pre- and perioperative
factors were stratified by flap type (Table 2). Preoperative factors,
including patient age, gender, and ASA status, did not vary. There were
significant differences, however, in tumor site and stage. Patients who
TABLE 2 Pre- and perioperative factors by flap typea
Variable ALT (32) FFF (42) RFFF (208) P value
Age (y) 65.8 (10.6) 63.3 (11.8) 64.9 (12.5) .487
Female, no. (%) 14 (43.8) 14 (33.3) 84 (40.4) .615
ASA 3 or 4, no. (%) 23 (71.9) 18 (42.9) 128 (61.5) .074
Tumor site <.0001
Cutaneous/temporal 3 (9.4) 1 (2.4) 25 (12.0)
Hypopharynx 1 (3.1) 0 (0) 14 (6.7)
Larynx 1 (3.1) 0 (0) 36 (17.3)
Oral cavity 7 (21.9) 41 (97.6) 104 (50)
Oropharynx 7 (21.9) 0 (0) 17 (8.2)
Sinus/maxilla 13 (40.6) 0 (0) 12 (5.8)
Stage <.0001
I-III 8 (25.8) 1 (3.2) 128 (68.1)
IV 23 (74.2) 30 (96.8) 60 (31.9)
ORN (yes) 0 (0) 7 (16.7) 13 (6.3) .068
Preoperative XRT 17 (53.1) 12 (28.6) 97 (46.6) .059
Packed Red Blood Cell transfusion 21 (65.6) 19 (45.2) 98 (47.1) .131
Flap take back (yes) 4 (12.5) 5 (11.9) 27 (13.0) .981
In-hospital cardiac issue 0 (0) 6 (14.3) 15 (7.2) .072
In-hospital pulmonary issue 5 (15.6) 5 (11.9) 12 (5.8) .067
In-hospital nonwound infection (PNA or UTI) 6 (18.8) 7 (16.7) 31 (14.9) .797
In-hospital wound breakdown or fistula 7 (21.9) 4 (9.5) 32 (15.4) .377
In-hospital surgical site infection 4 (12.5) 4 (9.5) 17 (8.2) .614
Mean LOS (d) (SD) 14.8 (9.4) 13.9 (6.7) 12.6 (7.6) .125
Median LOS (d) (IQR) 12 (9) 11 (7) 10 (6) .094
Note: Surgical site infection includes about donor and recipient sites.
Abbreviations: ALT, anterolateral thigh; ASA, American Society of Anesthesiology Physical Classification; FFF, fibular free flap; IQR, interquartile range;
LOS, length of stay; ORN, osteoradionecrosis; PNA, pneumonia; RFFF, radial forearm free flap; UTI, urinary tract infection; XRT, radiation.
aThere were no statistically significant differences in patient demographics and preoperative characteristics across flap type except for tumor site and
tumor stage. Student's t test and the Kruskal-Wallis test were used for quantitative data, while chi-square test was used to analyze proportional data.
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underwent FFFs more commonly had stage IV tumors located in the
oral cavity. History of prior radiation therapy was more common among
patients who underwent RFFF as compared to those who had ALT or
FFF patients. Though not significantly different, the data for in-hospital
cardiac and pulmonary issues were variable across flap type.
3.3 | Length of stay
The mean LOS was 13 days (SD = 7.7, range 4-65). Duration of stay
was similar when stratified by flap type (14.8 ± 9.4 days for ALT,
13.9 ± 6.7 days for FFF, and 12.6 ± 7.6 for RFFF). Median LOS was
10 days (interquartile range = 7), and was also not significantly differ-
ent across flap types (Table 2). In bivariable analysis, preoperative
radiation (XRT) was associated with a significant increase in LOS of
approximately 2.5 days (Figure 1A). Wound complication (breakdown
or fistula) was also associated with a significant increase LOS of
approximately 4 days (Figure 1B). Finally, patients who returned to
the operating room for flap take back had a significantly longer LOS
as compared to those who did not (Figure 1C).
3.4 | Multivariable analysis of pre- and
perioperative factors associated with greater LOS
A multivariable regression model was performed to identify factors
associated with greater LOS (Table 3). Significant predictors of
increased LOS included flap take back (beta coefficient [C] = +4.26,
P < .0001), in-hospital PNA or UTI (C = +2.52, P = .037), wound break-
down or fistula (C = +5.0, P < .0001), SSI (C = +3.54, P = .017), and his-
tory of prior radiation therapy (C = +2.59, P = .004) (Table 3). Of note,
there was no significant difference in LOS between patients who had
either PNA, a UTI, or both PNA and a UTI.
4 | DISCUSSION
In this study, we investigated the factors that may affect LOS for head
and neck cancer free flap reconstructive surgeries in 282 patients at a
tertiary medical center. Flap take back, postoperative PNA or UTI, wound
breakdown or fistula, SSIs, and history of prior radiation therapy were
associated with increased LOS. Notably, flap type was not associated.
F IGURE 1 Univariable analysis of factors associated with increased length of stay. A, Preoperative radiation (XRT); B, Wound
complication; C, Flap take back
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Head and neck cancer free flap patients are often at increased
risk for postoperative infection due to multiple wound areas, clean-
contaminated operation sites, underlying comorbidities, and pro-
longed operation time.17 SSIs and wound complications (breakdown
or fistula) were associated with substantially increased LOS. The liter-
ature reports that SSIs can occur in up to 22% to 39% of head and
neck cases, even with the use of antibiotic prophylaxis.13 Other head
and neck studies not only corroborate that SSI is an independent risk
factor for LOS, but also show that SSI increases the risk for 30-day
readmission.14,18-20 Past studies have explored the use of postopera-
tive antibiotic prophylaxis; however, no randomized controlled study
has demonstrated a significant reduction in SSIs with postoperative
prophylaxis.17 Of note, programs implementing infection-control pro-
tocols such as the Center for Medicare and Medicaid's National Surgi-
cal Care Improvement Project have demonstrated a lower than
expected rate of SSIs.17,21 Type and duration of perioperative antibi-
otic prophylaxis, degree of wound surveillance postoperatively, and
rehabilitative support are interventions that have the potential to suc-
cessfully diminish infection rate.22-24
Postoperative nonwound infections, such as PNA and UTI, repre-
sent common yet avoidable postoperative complications that prolong
discharge in head and neck cancer patients. Past studies have found
that hospital acquired pneumonia occurs in as many as 4.7% to 9.7%
of head and neck patients postoperatively, but few have examined its
impact on LOS.25-27 Penel et al showed that postoperative pneumonia
was correlated with an increased LOS; however, prolonged antibiotic
use after free flap construction may not decrease pneumonia risk.13
Khariwala et al demonstrated that a prolonged course of antibiotics
was actually associated with a higher risk of pneumonia in free flap
patients.28 Additionally, other respiratory complications such as pro-
longed ventilator dependence are associated with increased LOS.20
To date, there has been limited data surrounding antibiotic type and
duration to minimize nonwound infections in complicated free flap
surgical patients.17 Head and neck surgical teams should explore both
pharmacological measures, such as optimizing perioperative antibi-
otics, and nonpharmacological measures, such as early ambulation,
local antiseptic care, and greater care with intubation and urinary
catheter placement.29
History of radiation therapy was associated with increased LOS.
It is notable that the majority of head and neck free flap studies dem-
onstrate a positive association between preoperative radiation ther-
apy and postoperative infectious complications or flap survival.30-35
Robust infection prevention protocols may prove especially beneficial
for patients with a history of radiation therapy.
Past studies have found that increased operative time may be
associated with increased LOS in free flap patients.20 In our cohort,
operative time was not significantly associated with increased LOS.
With improvements in free flap surgical techniques and down
trending operative times, operative time may not be a strong predictor
of postoperative complications.16 Operative time may also be a proxy
TABLE 3 Multivariable linear regression of pre- and perioperative factors associated with greater length of stay
Variable Beta coefficient 95% Confidence interval P value
Preoperative and demographic factors
Female gender (vs male) −1.11 −2.87 to −0.66 .217
Age (per 1 additional year) + 0.05 −0.02 to 0.13 .162
Stage IV (vs stage I-III) + 0.02 −1.91 to 1.96 .982
History of ORN + 1.45 −6.36 to 9.27 .715
Preoperative XRT + 2.59 0.84-4.35 .004
ASA 3 or 4 (vs 1-2) + 1.09 −0.65 to 2.82 .219
Flap type
ALT REF
FFF + 2.31 −1.15 to 5.78 .189
RFFF −0.01 −2.73 to 2.72 .999
Perioperative complications (yes vs no)
Transfusion +0.89 −0.86 to 2.63 .317
Flap take back +4.26 1.68-6.84 .004
Cardiac complication +2.60 −0.69 to 5.88 .120
Pulmonary complication +1.80 −1.47 to 5.08 .280
Nonwound infection (PNA or UTI) +2.52 0.15-4.89 .037
Wound breakdown or fistula +4.98 2.60-7.35 <.0001
Surgical site infection +3.54 0.63-6.45 .017
Note: Surgical site infection includes both donor and recipient sites.
Abbreviations: ALT, anterolateral thigh; ASA, American Society of Anesthesiology Physical Classification; FFF, fibular free flap; LOS, length of stay; ORN,
osteoradionecrosis; PNA, pneumonia; RFFF, radial forearm free flap; UTI, urinary tract infection; XRT, radiation.
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for surgical complexity and increase the risk for complications
and LOS.
Nonmodifiable preoperative patient-specific factors (eg, history
of chemotherapy and/or radiation) are associated with increased LOS,
and should be taken into account when planning for patient disposi-
tion. The factors can also be used to identify patients who may be at
higher risk for perioperative complications. Institution-specific prac-
tices may also play a role, and merit further exploration. For example,
we previously found that LOS and hospital mortality are comparable
to nonacademic centers, even though academic center patients are
often more complicated, and have higher rates of chemotherapy and
radiation.36 Careful attention to history of radiation and other clinical
factors associated with complications and increased LOS may opti-
mize the quality of patient care and minimize related health care
expenditures.
This study is limited by its retrospective design, potential for
absence of other confounding variables not ascertainable in the
patient's medical record. Other variables worth investigating in future
studies include postoperative delirium, substance use or withdrawal,
need for postacute care, and need for tracheostomy or feeding tube
at discharge. The sample size of this study is relatively small, includes
more males than females, and samples patients from only a single
institution. To control for institution-specific factors that could influ-
ence LOS, future studies with a broader, more diverse study popula-
tion can help to confirm these findings.
Ultimately, this study demonstrates that multiple factors may be
associated with significantly increased LOS, many of which may be
modifiable. Though high-volume free flap programs often have
established perioperative protocols, efforts to optimize care pathways
and minimize LOS continue to be essential. Further studies that pro-
spectively investigate the impact of programs targeting these factors
would be valuable in better understanding their merit and potential
for intervention.
5 | CONCLUSION
This study identifies several pre- and perioperative factors during
head and neck free flap reconstructive surgery that are associated
with increased LOS. Initiatives to address these factors could
decrease LOS, leading to hospital savings and improved patient
outcomes. These initiatives may include optimizing perioperative
antibiotic use, as well as the institution of specific protocols to
minimize risk for SSI and medical complications such as PNA
and UTI.
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